Latest Period
Q2 2026
Security Snapshot
Scilex Holding Co - Common Stock, $0.0001 par value per share (SCLX) Institutional Ownership
CUSIP: 80880W205
13F Institutional Holders and Ownership History from Q2 2024 to Q2 2026
Institutions Reporting
70
Shares (Excl. Options)
702,751
Price
$7.80
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Symbol
- SCLX on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 702,751
- Total 13F value
- $5,481,551
- Portfolio coverage rank
- 0%
- Share change
- -168,968
- Value change
- -$942,400
- Number of holders
- 70
- Shares outstanding
- 263,415,596
- SEC-reported price per share
- $7.39
- Insider filing price
- $7.39
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- SCLX - Scilex Holding Co - Common Stock, $0.0001 par value per share is tracked under CUSIP 80880W205.
- 70 institutions reported positions in Q2 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 69 to 70 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $5,805,880 to $5,481,551.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 70 institutions filings for Q2 2026.
Security key
80880W205
Latest holder period
Q2 2026
13F holders
70
13D/G owners
3
CIK / CUSIP context first
Open Q2 2026 holders
SCLX full holder history
Scilex Holding Co SEC filings
Scilex Holding Co company facts
Scilex Holding Co insider transactions
Scilex Holding Co 13D/G history
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 80880W205:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
SCLX
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| SCLX Stock Acquisition JV LLC | 11% | $234,280,198 | 30,029,378 | SCLX Stock Acquisition JV LLC | 03 Jul 2026 | |||
| ARMISTICE CAPITAL, LLC | 8.6% | $31,008,000 | 4,800,000 | Armistice Capital, LLC | 30 Jun 2025 | |||
| ORAMED PHARMACEUTICALS INC. | 4.9% | -50% | $5,438,249 | -$4,921,820 | 437,510 | -48% | Oramed Pharmaceuticals Inc. | 31 Dec 2025 |
As of 30 Jun 2026, 70 institutional investors reported holding 702,751 shares of Scilex Holding Co - Common Stock, $0.0001 par value per share (SCLX). This represents 0.27% of the company’s total 263,415,596 outstanding shares.
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
9
Latest
Q2 2026
Rows shown
1-9 of 9
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 702,751 | $5,481,551 | -$942,400 | $7.80 | 70 |
| 2026 Q1 | 871,717 | $5,805,880 | -$2,086,274 | $6.66 | 69 |
| 2025 Q4 | 1,119,739 | $13,661,197 | +$3,630,948 | $12.20 | 78 |
| 2025 Q3 | 759,753 | $14,960,373 | +$3,238,244 | $19.68 | 79 |
| 2025 Q2 | 619,696 | $3,649,745 | +$3,564,555 | $5.89 | 63 |
| 2025 Q1 | 42,004 | $10,442 | +$10,434 | $0.25 | 4 |
| 2024 Q4 | 19 | $8 | $0.42 | 1 | |
| 2024 Q3 | 19 | $18 | $0.95 | 1 | |
| 2024 Q2 | 19 | $37 | +$37 | $1.95 | 1 |